Simple Summary The clinical management of bladder cancer has been developing in the
past decade, including diagnostic tools and treatment options. Both monotherapy and …

The aim of this review is to analyze and describe the current landscape of bladder cancer
diagnostic and surveillance biomarkers. We researched the literature from 2016 to …

Background Current non-invasive tests have limited sensitivities and lack capabilities of pre-
operative risk stratification for bladder cancer (BC) diagnosis. We aimed to develop and …

Simple Summary Bladder cancer (BC) is the tenth most common cancer worldwide, with
approximatively 550,000 new cases and 200,000 deaths in 2018. BC is divided into two …

Urothelial bladder cancer is a complex disease displaying a landscape of heterogenous
molecular subtypes, mutation profiles and clinical presentations. Diagnosis and surveillance …

Background and objective Diagnosis of primary and relapsed bladder carcinomas is
accomplished by urethrocystoscopy, an invasive procedure, combined with urinary cytology …

Objective: The goal of the current trial was to investigate the expression levels of tumor
necrosis factor-α (TNF-α) and soluble interleukin-2 receptor (SIL-2R) in serum of patients …

Background Bladder cancer (BLCA) is one of the most common malignancies among tumors
worldwide. There are no validated biomarkers to facilitate such treatment diagnosis. DNA …